Device type · CFF
Immunoelectrophoretic, Immunoglobulins, (G, A, M)
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
CFF
Immunology
Device class
Class II
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Immunoelectrophoretic, Immunoglobulins, (G, A, M)
- Product code
- CFF
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CFF
Latest FDA decisions
K203184 · Decided Nov 12, 2021 · 381 days after receipt
Device type: Immunoelectrophoretic, Immunoglobulins, (G, A, M) (CFF) · Laboratory Medicine & Pathology
K192095 · Decided Nov 1, 2019 · 88 days after receipt
Device type: Immunoelectrophoretic, Immunoglobulins, (G, A, M) (CFF) · Laboratory Medicine & Pathology
K190851 · Decided May 2, 2019 · 30 days after receipt
Device type: Immunoelectrophoretic, Immunoglobulins, (G, A, M) (CFF) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013Open, Classified
Kamiya Biomedical Company, LLC
Z-0271-2023 · Started Sep 28, 2022 · Posted by FDA Nov 21, 2022
Reason given: IgA Reagent may start showing cloudiness over time, which can affect assay performance.
Cause as FDA categorized it: Under Investigation by firm
- V8 Immunodisplacement Kit REF 1803Open, Classified
Z-1244-2022 · Started Apr 6, 2022
Reason given: Due to microbial growth causing interference with interpretation.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-0045-2020 · Started Jul 21, 2017
Reason given: The plates do not have wells punched for the controls in the patient 1 area.
Cause as FDA categorized it: Employee error
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.